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Referrals of women with a family history of breast cancer from
primary care to cancer genetics services in South East Scotland
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M Porteous2
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Crewe Road South, Edinburgh EH4 2XU, UK; 4SE Scotland Breast Screening Service, Ardmillan House, Ardmillan Terrace, Edinburgh EH11 2SL, UK;
5Cancer Research UK, Edinburgh Oncology Unit, Western General Hospital, Crewe Road South, Edinburgh EH4 2XR, UK; 6Lothian NHS Board,
Deaconess House, 148 Pleasance, Edinburgh EH8 9RS, UK; 7School of Biology, University of St Andrews, St Andrews, Fife KY16 9TS, UK
As part of a cluster randomised trial to assess an alternative model of cancer genetics services, we gathered data on all referrals from
general practitioners (GPs) to cancer genetics services in South East Scotland over a 4-year period. The referral rate per 1000
patients rose by 48% from 0.21 in the 2-year period before the trial to 0.31 during the trial. This increase was much greater in the trial
group offered the GP clinic service (64% increase compared to a 38% increase in those referred to the regional service). Thus, the
offer of a more local service appeared to have a marked effect on GP management of these women. Referral rates to cancer genetics
services from general practices varied widely with higher referral rates from practices with more female partners. There was a
negative correlation between referral rates and practice area deprivation scores. However, this was not found during the trial in the
group which offered clinics in general practice, the provision of clinic appointments nearer to the homes of more socially deprived
women resulting in improved access to women from deprived areas. The interaction with the GP appears to be associated with an
inappropriate level of interest in and expectation of the appropriateness of genetic testing. The provision of the clinics within general
practice did not result in higher levels of confidence among GPs in managing these women.
British Journal of Cancer (2003) 89, 1650–1656. doi:10.1038/sj.bjc.6601348 www.bjcancer.com
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UK genetic services are based on a network of regional centres
offering specialist services (diagnosis, risk assessment, counselling,
surveillance and support) to families at high risk of serious genetic
disorders. While links with secondary and tertiary specialists are
established in most centres, links with primary care are in the
process of development (Donnai and Elles, 2001).
Family history is known be a significant risk factor for breast
cancer. Awareness of the genetic component of certain forms of
cancer and therefore the potential importance of a family history is
increasing among the population. This, in turn, has resulted in an
increasing number of self-referrals to general practitioners (GPs),
and subsequently to clinical genetics services (Campbell et al,
1995). A survey of 22 regional cancer genetics services in the UK in
1998 reported that the predominant users of these services were
women with a family history of breast cancer (Wonderling et al,
2001).
Of women who are diagnosed with breast cancer, about 10%
report of having a family history of the disease. We have recently
found, in a large population-based survey of family history of
breast cancer, that 52% of adult women have at least one first- or
second-degree relative with breast cancer. Thus, all GPs will have
many patients with first-degree relatives with breast cancer and
many of these patients are likely to seek counselling and advice
regarding their level of risk.
The aims and objectives of genetics services responding to the
increasing public recognition of family history of cancer have been
described in detail (Ponder, 1994). The provision of cancer
genetics services has been seen as one of a number of cancer-
control strategies located in primary care (Austoker, 1994). In
South East Scotland, a multidisciplinary clinic offering specialist
cancer genetic risk counselling and screening to women with a
family history of breast cancer has been held in the regional breast-
screening centre in Edinburgh since 1992. This clinic accepted
direct referrals from GPs or other hospital consultants.
We had previously proposed an alternative model of cancer
genetics services (Campbell et al, 1995), whereby genetics nurse
specialists could offer risk estimation based on an assessment of
the family history of cancer within clinics held in GP locality areas.
This would be accompanied by appropriate counselling for those
whose empiric risk was not significantly increased and by
immediate referral to regional specialist services for those at
higher risk. It was hoped that this would provide improved
support to primary care and more appropriate services for those at
lower risk while encouraging more cost-effective use of specialist
resources for those at increased risk of developing breast cancer.
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We carried out a cluster randomised trial of this new model of
service delivery comparing it to the existing multidisciplinary
specialist service. As part of the data collection for this trial, we
gathered structured data on all GP referrals to cancer genetics
services in the South East of Scotland over a 4-year period. In this
report, we present data on rates of referral of women to regional
cancer genetics services for further assessment of their family
history of breast or breast/ovarian cancer before and during the
period of the trial. We identify and discuss factors that influence
these referral rates and report the views of GPs about their role in
the management of women with a family history of breast cancer
and their attitudes to the services available to them.
METHODS
Referral by GPs to cancer genetics services
We defined a study population as the patients registered with
general practices within the catchment region of the SE Scotland
Cancer Genetics and Breast services. We calculated the total
number of referrals from all 203 general practices in this region,
which were approached to take part in the study during a 24-
month period before the trial started and the 21-month period of
the trial. The total number of patients on the lists of all these
general practices was 1 221 261 at the beginning of the trial. The
referral rate was estimated by
ðtotal referrals per yearÞ1000=ðtotal list size for all general practicesÞ:
Thus, the referral rates to cancer genetics services before and
during the trial were taken as the number of women referred per
1000 patients on the general practice lists during the periods from
1 May 1995 until 30 April 1997 and from 1 March 1998 until 30
November 1999, respectively. Referral rates for individual general
practices were calculated in a similar fashion.
The Carstairs deprivation score that is based on postcode of
residence was used as a measure of social deprivation of patients
registered with general practices (Carstairs and Morris, 1990) with
high positive deprivation scores being indicative of greater
deprivation. For general practices in Lothian Region, deprivation
scores for all patients registered with each practice were averaged
to give a mean score for each practice. For general practices in Fife
and Borders regions, individual scores were not available so we
adopted the score for the postcode of the surgery address to
represent the practice.
In order to assess whether differences in referral rates might be
in part due to less selective referral criteria used by practices with
higher referral rates (resulting in a greater proportion of women
with a low risk of developing breast cancer), we classified general
practices into four groups according to their referral rate during
the trial. In each of these four groups, we calculated the proportion
of referrals that were estimated to be at high, moderate and low
risk based on an assessment of family history information given in
the GP referral letter, thus reflecting the information available to
the GP at the time of referral. In a few cases, the information in the
GP letter was insufficient for an accurate risk assignment and so
these women were omitted.
Women were asked if they had taken the first step by asking to
be referred or if this had been suggested to them by their GP, a
hospital doctor or another medical professional. Those who said
that they had taken the initiative themselves were asked if this was
because of their own concern, the suggestion of another family
member, because of something in the press or for another reason.
Summary of the conduct of the trial
Ethical approval for the study was obtained from the local research
ethics committee. An invitation to take part in the trial was sent to
all general practices in Lothian (n¼ 125), South West Fife (n¼ 54)
and Borders (n¼ 24) National Health Service (NHS) Boards in
South East Scotland. A total of 170 practices (84%) agreed to take
part, 23 (11%) declined and 10 (5%) did not reply. This meant that
725 of the 828 (88%) GPs in practice across these three NHS Board
areas agreed to refer patients into the trial. Practices were
randomly assigned to either arm of the trial using a minimisation
technique (Pocock, 1983) to ensure that the two groups were
balanced for size of practice, historical referral rate to cancer
genetics services and social deprivation index.
During the period from March 1998 to November 1999, any
woman referred from participating GP practices to the regional
clinical genetics department for breast cancer genetic risk
estimation and counselling was invited to take part in the trial.
To be eligible for the trial, women had to live in the region, be able
to give informed consent and to complete a baseline questionnaire.
Women were asked to record their date of birth, marital status and
educational level on the baseline questionnaire. Information about
the category of risk to which each woman had been assigned was
derived from the clinical records.
Women who were symptomatic or had been diagnosed with
breast and/or ovarian cancer or who had previously consulted
another clinic about their family history of cancer were excluded
from the trial. Those who were ineligible to participate,
nonresponders and those who did not consent to participate in
the trial were offered an appointment by the regional genetics
service. The service offered to women who were enrolled in the
trial was dependent on the arm of the trial to which their GP
practice had been randomised.
Women referred by the first (‘regional clinic’) group completed
a family history form and those considered to be at increased
genetic risk (i.e. in the ‘moderate-risk’ or ‘high-risk’ categories)
received the existing service that comprised an appointment to see
a consultant geneticist and breast surgeon at a regional centre.
Women referred by the second (‘community clinic’) group were
seen at one of several clinics held in a community setting relatively
near the woman’s own general practice.
At the community clinic, the genetics nurse specialist ascer-
tained the woman’s family history of cancer and compiled a family
tree. This information was compared to published criteria to
determine whether she was at increased risk. When an adequate
risk assessment could not be made during the appointment,
further information and/or confirmation of relatives’ diagnoses
were obtained from the woman or medical records or from cancer
registry data, before the woman was informed of their risk by
letter. Women whose risk of breast cancer was estimated not to be
increased over that of women of a similar age in the general
population (i.e. in the ‘low-risk’ category) were offered informa-
tion and reassurance and were discharged from the clinic. These
women and their GPs were sent a letter reaffirming their low-risk
status and summarising the issues discussed at the appointment.
Women whose risk was estimated to be increased over that of
women of a similar age in the general population were offered an
appointment at the regional centre with a consultant breast
surgeon and genetics nurse specialist. Further details of the trial
interventions are given in a related publication (Fry et al, 2003).
Psychological distress and cancer worry were measured by the
general health questionnaire (GHQ 30) (Goldberg and Williams,
1988) and the Cancer Worry Scale (Watson et al, 1998) as
described by Fry et al (2003).
Questionnaire survey of general practices who participated
in the trial
All GPs who referred women during the study period received a
questionnaire asking their views about various aspects of the
management of women with a family history of breast cancer.
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Statistical methods
w2 tests were used to compare the distribution of sources of referral
before and during the trial, the risk statuses of women who were
referred by practices with different referral rates, and the responses
of women who had or had not been given information by their
GPs. Comparisons were made between referral rates within trial
groups using the paired t-test. Comparisons of the number of
practice members and female practice members were made using
the Spearman rank correlation coefficient since these were not
normally distributed. Pearson’s correlation coefficients were
calculated between locality (Carstairs) deprivation scores and
referral rates before and during the trial for all Lothian practices.
RESULTS
Referral rates to cancer genetics services
General practices approached to take part in the study A total of
203 practices in the Lothian, Borders and South-West Fife regions
of Scotland were approached to take part in the study. Some 170
(84%) agreed to take part, 23 (11%) refused and 10 (5%) did not
reply.
Changes in referral rates to cancer genetics services over time The
referral rate (and 95% confidence interval) per 1000 patients on the
GP lists rose from 0.21 (0.19–0.24) in the 2-year period before the
trial to 0.31 (0.28– 0.34) during the trial. Thus, there was a 48%
increase in referral rate over this period of approximately 2.5 years,
a highly significant difference (Po0.001).
Change in referral behaviour of GPs Prior to the study, many
asymptomatic women with a positive family history were referred
to the Edinburgh Breast Unit (symptomatic breast clinic) and then
referred on, after receiving a mammogram and an appointment
with a breast surgeon, to the cancer genetics clinic. In order to
assess if there had been a change in this pattern of referral during
the period of the study, we compared the referral sources of this
group of asymptomatic women (with a positive family history of
breast cancer) before and during the trial. The letter sent out at the
start of the trial to all GPs requesting that referrals be directed to
cancer genetics services rather than to symptomatic breast services
was successful, with the proportion of referrals from the
symptomatic breast service falling from 24.6% before the trial to
14.5% during the trial. There was a highly significant difference
between the sources of referral before and during the trial (Po
0.001).
Relationship between referral rate and risks of women referred Of
the general practices that agreed to take part in the study, 30
referred no women during the study period. Annual referral rates
during the trial for other practices varied by more than 30-fold,
ranging from 0.05 to 1.66 per 1000 registered patients. The
proportions of referrals that were estimated to be at high,
moderate or low risk (based on information in the GP referral
letter since this was the information available to the GP at that
time) by four strata of general practice referral rates are given in
Table 1. This shows that although general practices with the lowest
referral rates referred a smaller percentage of low-risk women,
there was no statistically significant trend in the proportions of
risk classifications across the referral rate strata. Thus, we found
no strong evidence that higher referral rates reflect the use of less
selective referral criteria by these general practices.
Relationship between referral rates and number and sexes of
partners in the practice Of the practices that had agreed to take
part in the study, 15% had no female partners, 67% had one to two
female partners and 19% had three or more. Neither referral rate
before nor during the trial was correlated with the number of
partners or the number of male partners in the practice. However,
there is a small but significant correlation between both referral
rates and the number (Spearman rank correlation coefficient 0.24,
Po0.002; 0.23, Po0.003) and proportion (Spearman rank
correlation coefficient 0.22, Po0.005; 0.17, Po0.02) of female
partners in the practice before and during the trial, respectively.
Comparison between referral rates in the two trial groups Table 2
gives the mean referral rates before and during the trial-by-trial
group. There was a statistically significant increase in referral rate
between the two time periods in both trial groups (regional group
Po0.01; community group Po0.001). This increase was greater in
the community clinic trial group (64% increase compared to a 38%
increase in the regional group over rates before the trial).
Relationship between referral rates and locality deprivation scores
of general practices We calculated the correlation between the
locality (Carstairs) deprivation score and referral rates before and
during the trial for all Lothian practices (whether or not included
in the trial) to investigate whether general practices serving women
who were more socially deprived would have lower referral rates
than those serving less socially deprived women. The correlation
coefficients were 0.26 (Po0.01) with referral rates before the
Table 1 Numbers (percentages) of referrals classified as high, moderate and low risk of breast cancer (due to family history based on national criteria) by
practice groups with differing referral rates (annual rate per 1000 women on general practitioner list)
Risk classification following national guidelines
Referral rate during trial Number of general practices High risk Moderate risk Low risk Total referrals
p0.19 41 7 (11.1%) 48 (76.2%) 8 (12.7%) 63
0.20–0.33 28 11 (13.3%) 55 (66.3%) 17 (20.5%) 83
0.34–0.54 39 26 (12.1%) 133 (62.1%) 55 (25.7%) 214
X0.55 31 23 (12.8%) 116 (64.8%) 40 (22.3%) 179
Total 139 67 352 120 539
Table 2 General practitioner (GP) referral rates (per 1000 patients on
GP list per year) to cancer genetics services before and during the trial
(mean and 95% confidence limits)
GP group
Before trial
mean (95% CI)
During trial
mean (95% CI)
Percentage
increase in
referral rate
Regional group 0.21 (0.17–0.26) 0.29 (0.23–0.34) 38.1
Community group 0.22 (0.17–0.26) 0.36 (0.29–0.43) 63.6
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trial and 0.13 (not statistically significant) with referral rates
during the trial, suggesting that the tendency for practices serving
less deprived areas to have higher referral rates was reduced
during the time of the trial. Table 3 shows that the relationship
between referral rate and locality deprivation score in general
practices is influenced by the provision of community clinics.
There was a negative correlation between referral rate and locality
deprivation score both before and during the trial in the regional
trial group. This indicates that practices in areas of lower social
deprivation had higher referral rates. The same was true of the
community trial group before the trial but during the trial the
correlation was almost zero. Although the difference in referral
rates between the two groups did not reach statistical significance,
the lack of change in the regional but not the community trial
group is striking (Table 3).
Patient’s role in the referral by the GP In all, 43% of women
indicated that they had asked to be referred (in contrast to the
others for whom referral was suggested to them by their GP or
another medical professional). Two-thirds of these women noted
that this was based on their own concern with the others
requesting referral at the suggestion of another family member.
Younger women were more likely to have taken the initiative to
request referral (50% of women under 40 years compared to 31%
of those 40 years or over, P¼ 0.001, w2 test).
Of those that stated that their GP (or other medical professional)
had initiated the referral, only a third stated that they had
specifically enquired about their family history of cancer; for over
one-half the suggestion of referral had taken place when they had
seen the doctor about another matter. There was no significant
difference in educational status, perceived level of risk or cancer
worry between the two referral groups.
Women’s views of information given to them by their GP
prior to referral
Women enrolled in the trial were asked questions about whether
any information had been given to them by their GP about their
family history of cancer prior to the referral. About 40% of women
had received no such information. In total, 50% of those who had
received information reported that they found it to be very helpful
or helpful. Women were then classified into two groups according
to whether or not they had received information.
The only statistically significant difference between the two trial
groups (after correcting for the number of comparisons made (by
the Bonferroni method) related to views on genetic testing. In all,
90% of those who had received information from their GP thought
that it was very important or quite important to have genetic
testing compared with 73% of those who had not received
information from their GP (Po0.01). Similarly, 71% of the group
who had received information from their GP stated any informa-
tion from a genetic test would be very important compared with
56% of those who had not received information from their GP, but
this difference was not statistically significant.
General practitioners’ views about the management of
women presenting with a family history of breast cancer
All GPs who referred women during the period of the trial received
a questionnaire asking their views about various aspects of the
management of women with a family history of breast cancer.
Completed questionnaires were received from a total of 129 GPs in
the regional group and 115 GPs in the community group.
General practitioners’ confidence in fulfilling their role in cancer
genetics services Table 4 shows the percentages of GPs having
various degrees of confidence in handling various aspects of the
management of these women. General practitioners in both groups
were most confident about taking a family history, providing
emotional follow-up support and regular clinical examination and
teaching breast self-examination. They were much less confident
about calculating the risk and counselling on the basis of this and
less confident about discussing the need for mammographic
screening and deciding about whether a patient should be referred
to the genetic clinic. There were no marked differences between the
two trial groups suggesting that the limited number of contacts
between the GPs and the genetics nurses who staffed the
community clinics was insufficient to alter GP confidence in the
management of these women. There was little evidence of GPs
taking advantage of the presence of the nurse within the practice to
discuss genetics issues.
General practitioners’ attitudes to genetic counselling and active
screening for family history of breast cancer Over 90% of GPs
agreed or strongly agreed that cancer genetic counselling has a
useful role for women with a family history of breast cancer, and
over 85% agreed or strongly agreed that mammography has a
useful role for those at increased risk. In contrast, however, only
Table 3 Correlations between general practitioner-referral rates and
locality (Carstairs) deprivation scores (higher score in more deprived areas)
by trial group
Trial group
Correlation with
referral rate before
trial
Correlation with
referral rate during
trial
Regional group 0.26 0.28
Community group 0.23 0.01
Table 4 Percentages of general practitioners expressing their degree of confidence in fulfilling various roles in the management of women presenting with
a family history of breast cancer
Not confident or a little confident Moderately confident Confident or very confident
Regional Community Regional Community Regional Community
Taking detailed family history 25.6 21.8 38.8 35.7 34.9 42.6
Calculating the risk 89.9 87.8 10.1 10.4 0 0.9
Counselling on risk 83.0 75.7 13.2 20.9 3.9 2.6
Providing emotional follow-up support 17.1 23.5 42.6 39.1 40.3 37.4
Providing regular clinical examination 29.4 21.8 37.2 40.9 33.4 37.4
Teaching breast self-examination 14.0 13.9 33.3 33.0 52.8 53.0
Discussing need for mammography/colonoscopy 28.7 33.0 42.6 41.7 28.7 25.2
Deciding whether patient should be referred to
regional genetic clinic
41.1 45.3 50.4 38.3 8.5 15.7
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30% agreed or strongly agreed that GPs should actively identify
those from their lists who might be eligible for genetic counselling.
General practitioners’ views on their information and training
needs General practitioners’ views on the potential utility of
various forms of support from regional clinical genetics services in
helping them deal with their increased workload are given in
Table 5. Referral guidelines were considered to be the most useful
support, with over 90% of GPs regarding them as useful or very
useful. Local clinics offering genetic counselling were regarded by
one-third as very useful. There was less enthusiasm for interactive
computer programs or direct access to screening. Over 50% of GPs
stated that training in genetic counselling for themselves or other
practice staff would be not at all useful or only a little useful. It is
possible, however, that this was due to their interpretation of the
term ‘genetic counselling’ and that a higher proportion of GPs
would favour some form of training to improve their skills. There
were no differences in responses between GPs in the two trial
groups.
General practitioners’ views on trial interventions
About two-thirds of GPs (62% of regional group GPs and 65% of
community group GPs) noted that they were confident or very
confident about their women being seen by a genetic nurse
specialist or genetic associate rather than by a consultant
geneticist. A similar proportion (61% of regional group GPs and
64% of community group GPs) noted that they were positive or
very positive about having genetic clinics in the community. When
asked whether they would prefer community clinics run by nurse
specialists or regional hospital-based genetic clinics about one-
third (36% of regional group GPs and 34% of community group
GPs) favoured the former and one-half (51% of regional group GPs
and 50% of community group GPs) the latter, the remainder being
undecided.
General practitioners found the structured summary letter the
most useful aspect of the service followed by the provision of local
community-based clinics (rated as useful or very useful by 44.4
and 37.4%, respectively). Other items (practice talks given by
genetics nurse specialists and telephone advice) were rated as
useful or very useful by less than a quarter of the GPs. General
comments made by GPs included that they had made little use of
the service and that women were less likely to default from
appointments at community clinics.
DISCUSSION
Specialist outreach clinics
Specialist outreach clinics in general practice increased throughout
the mid-1990s, reflecting a desire within the National Health
Service to move towards closer integration of primary and
secondary care services (Bailey et al, 1994). Within clinical
genetics, it is recognised that this has the potential to lead to
improved equity of access to high-quality regional services
(Donnai and Elles, 2001), although this has not been formally
evaluated. Within primary care, there has been a call to develop
strong links with regional genetics centres. This has stressed the
need to provide accurate information and support for the primary
care team and to undertake some genetic risk assessment and
counselling and facilitate appropriate referral within primary care
(Kinmonth et al, 1998).
There have only been a limited number of thorough evaluations
of outreach services across various disciplines. These have
reported improved waiting times, patient satisfaction and con-
venience to patients but have noted less efficient use of specialist
time, limited interaction between primary care and specialist staff
and concerns about access to these services not being uniform
throughout a region (Bowling et al, 1997).
Prevalence of family history of breast cancer and referral
rates to cancer genetics services
We recently carried out a large cross-sectional survey of 13 155
patients registered with GPs in Scotland (Wallace E et al, personal
communication). This found that a GP with an average caseload of
1700 patients would have 140 patients with a family history of
breast, colorectal or breast/ovarian cancer, and of these 10 would
meet national criteria for referral for risk assessment. Reported
referrals to regional services for consultation regarding a family
history of breast cancer suggested a referral rate of about 0.25
referrals per 1000 patients per year, consistent with the referral
rates found in this study. This is based on referral of patients who
presented spontaneously to their GP and not on any form of active
surveillance by GPs of family history of cancer within their practice
population.
During the study, there was nearly a 50% increase in
referral rate, compared with 1 –3 years prior to the study and
a greater proportion of referrals came directly from GPs. At the
start of the study period, local protocols, based on UK
recommended guidelines for the primary care management of
people with a family history of breast cancer, were developed
together with GP representatives and Health Board guidelines
groups. These local protocols were disseminated to all GPs
in South East Scotland. In addition, all GPs received a biannual
genetics update newsletter during the course of the study.
These factors are likely to have contributed to the increase in
referral rate.
A striking finding was the substantially greater increase in
referral rates from pretrial levels in the community clinic trial
group compared to the regional group (64% increase compared to
a 38% increase). Thus, in addition to the underlying general
increase in referral rates, the establishment of community clinics
resulted in a change in referral behaviour that resulted in a further
increase in referral.
Table 5 Percentages of general practitioners’ stating views on the usefulness of various forms of support for the management of women with a family
history of breast cancer
Not useful or a little useful Quite useful Very useful
Regional Community Regional Community Regional Community
Interactive computer program 34.1 37.4 47.3 36.5 17.1 22.6
Referral guidelines 9.3 6.1 45.0 43.5 45.7 48.7
Local clinics offering genetic counselling 27.2 20.9 44.2 42.6 28.7 33.9
Direct access to medical genetic screening 36.4 38.2 41.9 38.3 20.2 19.1
Training for yourself in genetic counselling 57.4 56.5 29.5 30.4 13.2 10.4
Training for other primary care staff in genetic counselling 64.3 56.6 27.9 30.4 7.0 11.3
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Despite the increase in referral rates that we recorded over this
3-year period, these rates are considerably lower than those (15 out
of 1000 adult women/year) at which women reportedly raise
concerns about family history of breast cancer with their GP
(Kinmonth, 2001) suggesting that the GP ‘gatekeeper’ role is an
important one.
There was a very wide (more than 30-fold) variation in the
annual referral rates. The reasons for this are not clear, but there
was a small but significant correlation between referral rates
during the trial and the number and proportion of female partners
in the practice. Referral rates were greater from those practices
with a greater number of female partners and this could be because
women with a family history are more likely to seek the advice of a
GP, if the GP is female. Thus, if the patient belongs to a practice
where it is impossible or more difficult to see a woman, they may
be less likely to seek advice. Alternatively, it could be that female
GPs are more likely to refer women for genetic counselling about
breast cancer risk than male GPs.
We postulated that higher referral rates may reflect the use of
less rigorous selection criteria by some GPs. For example, this
might have occurred because of their knowledge that selection,
according to risk, for referral to the breast-screening service would
be performed subsequently by the genetic nurse who interviewed
the woman at the locality clinic. However, we found no evidence
that this had occurred.
We interpret our finding as follows. Family history of breast
cancer is common and many women consulting their GP may
mention this at the time of consultation (Kinmonth, 2001). We
found that younger women are more likely than older women to
raise this concern and request referral to specialist services.
General practitioners are operating at different thresholds at which
they take action on these concerns. We have already shown that
about 10% of women with a family history of breast cancer had
been referred to a specialist service by their GP (Wallace E et al,
personal communication). Once the decision to respond to this
concern is made by the GP, similar referral criteria are applied.
Currently, a more active surveillance of family history of cancer in
primary care (which would result in a much higher referral rate) is
not recommended in national cancer genetics guidelines nor is it
supported by GPs (in this survey only 30% agreed that GPs should
actively identify those from their lists who might be eligible for
genetic counselling).
Relationship between deprivation and referral rates to
cancer genetics services
There is an extensive literature that confirms that people from
different socioeconomic groupings consume health care in
different ways. This almost invariably shows that more deprived
people have worse health and have greater need for health care
(Balarajan et al, 1992; Eachus et al, 1996). It has been found that
15–20% of the overall variation seen in the overall GP referral
rates (to all services) can be explained by deprivation (Hippisley-
Cox et al, 1997). Disadvantaged groups have also been shown to be
less likely to attend for breast and cervical screening preventive
services (Eachus et al, 1996).
Provision of health care should be primarily determined by
need. However, access to secondary care has been reported to be
selectively poorer in deprived groups (Chaturvedi and Ben-
Shlomo, 1995). In this study, the correlation coefficient between
deprivation score and referral rate remained unchanged in the
regional group: 0.26 before the trial and 0.28 during the trial.
Thus, prior to and during the study in the regional group, there
was a tendency for practices serving less deprived areas to have
higher referral rates. The differential use of cancer genetics
services across deprivation groups may be influenced by factors
such as perceived risk and financial considerations (Eachus et al,
1996) or by health behavioural factors involving knowledge of
importance of family history, how personal risk is perceived and
what action is taken to seek counselling for a personal assessment
of high risk and the ability to articulate need to health service staff.
However, this relationship changed in the community group
with the establishment of new community clinics with the
correlation between deprivation score and referral rate before
the trial (0.23) falling to 0.01 during the trial. Thus, the
tendency for practices serving less deprived areas to have higher
referral rates was no longer found where community clinics were
held This is consistent with an interpretation that the provision of
clinic appointments nearer to the homes of more socially deprived
women and staffed by nurses results in GPs more likely to refer
and/or women being more willing to attend these clinics than more
distant regional clinics staffed by consultants. In addition, GPs
commented that women were less likely to default from appoint-
ments at community clinics.
Genetic testing We found that the interaction with the GP was
associated with an inappropriate level of interest in and
expectation of the appropriateness of genetic testing, with 90%
of those who had received information from their GP considering
it important or very important compared to 73% of those who had
not received information from their GP. While it is possible that
this was due to recall bias, we consider this unlikely and suggest
that this is worthy of further investigation. Since genetic testing is
only appropriate to a very small percentage of women with very
high familial risk, it is important that GPs do not foster this level of
expectation.
This mismatch in perception about the role of molecular testing
between those running cancer genetics clinics and women
attending them may need to be addressed specifically in the way
clinics are organised in the future and in postgraduate training of
GPs.
Views of GPs on new services and on their role in cancer
genetics
In general, GPs were confident about taking a family history,
clinical examination and offering emotional support. They
were less confident about risk assessment and deciding if
mammographic screening was necessary, and most did not
see it as their role to identify those from their lists who might
be eligible for genetic counselling. Several commented that they
and their staff did not have time to take on additional work of this
nature.
There were no marked differences between the two trial groups
suggesting that the limited number of contacts between the GPs
and the genetics nurses who staffed the community clinics were
insufficient to alter GP confidence in the management of these
women. This was reinforced by the written comments of a number
of GPs on the survey questionnaire that they had made little use of
the service (the average referral rate was 0.5 referrals per GP per
year). It has been noted previously that the limited interaction
between primary care and specialist staff jeopardises achievement
of one of the central aims of these initiatives – to facilitate
integration and overcome barriers between primary and second-
ary/tertiary care (Bailey et al, 1994).
In general, GPs were positive about their patients being seen by
genetic nurse specialists and about genetic clinics in the
community. However, one-half still favoured hospital-based rather
than locality clinics. General practitioners found the structured
summary letter the most useful aspect followed by the provision of
local community-based clinics. Most GPs regarded the referral
guidelines provided by the study as useful. Other items (practice
talks given by genetics nurse specialists, telephone advice and trial
newsletters) were rated as useful or very useful by less than a third
of the GPs.
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